Dr. John Cush RheumNow
3 years 9 months ago
The Top 10 Research Priorities in Psoriatic Arthritis
A survey of 317 carers and clinicians focused on psoriatic arthritis has set an agenda of the top 10 research questions for psoriatic arthritis (PsA).
https://t.co/qvcB3OkJUS https://t.co/EuD3qhOb5a
Dr. John Cush RheumNow
3 years 9 months ago
Why treatment of pre-RA isn't ready for prime time
The ACR Great Debate was on "To treat or not to treat in pre-RA?" and it was stressed that autoimmunity may start well before clinical symptoms occur.
https://t.co/TcKRc0w4i9 https://t.co/OkmlxTiAbm
Dr. John Cush RheumNow
3 years 9 months ago
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler ( @lianegensler discusses the following abstracts presented at #ACR22. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
https://t.co/f7o8UARKNl https://t.co/ryVmD86UoI
Dr. John Cush RheumNow
3 years 9 months ago
Systematic review of MSK findings in patients with acute lymphoblastic leukemia finds 29 pts with peripheral arthritis (7), axial manifestations (17), and osteolytic lesions (21 pts) & Vertebral Fx (4) Hypercalcemia in 9 cases. https://t.co/GJXoqhOjNG https://t.co/YHS09E4a0U
Dr. John Cush RheumNow
3 years 9 months ago
Tight control of proteinuria in newly diagnosed lupus nephritis
The last 3 years have been exciting times in the field of lupus nephritis (LN) with two new licensed therapies, belimumab (BAFF-inhibitor) and voclosporin (calcineurin-inhibitor).
https://t.co/Q7TahfZiB0 https://t.co/9Odwed55fe
Dr. John Cush RheumNow
3 years 9 months ago
Steroids in RA: Friend or foe (or both)?
Abstract 2000 presents longer-term follow-up data from the recently published GLORIA trial.
https://t.co/kNxwYMf59m https://t.co/rzRsZymlz3
Dr. John Cush RheumNow
3 years 9 months ago
RA: MACE Events with Opioids vs. NSAIDs
The authors of abstract 1646 assessed MACE (myocardial infarction, stroke, heart failure, CVD death, VTE) and all-cause mortality in new users of opioids vs. matched NSAIDs new users.
https://t.co/huz6NyYRlh https://t.co/dNYu7ybFZ5
Dr. John Cush RheumNow
3 years 9 months ago
Diffuse alveolar hemorrhage in antiphospholipid syndrome
https://t.co/Fx2fGcaNGS https://t.co/jFHUhvs5xV
Dr. John Cush RheumNow
3 years 9 months ago
Eosinophilia in systemic JIA patients after exposure to biologics
Dr. Bella Mehta discusses Abstract 0872 at #ACR22.
https://t.co/FI7KfDURr3 https://t.co/FqnqMPHJ3h
Hidradenitis suppurativa (HS) (also called acne inversa), is a chronic inflammatory skin disorder affecting apocrine gland-bearing skin in the axillae, groin, and under the breasts and is characterised by persistent or recurrent and painful boil-like nodules and abscesses. HS is associated with significant comorbidit
Dr. John Cush RheumNow
3 years 9 months ago
Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE
https://t.co/qJ8YbJ2Y6A https://t.co/deZKc1835I
Dr. John Cush RheumNow
3 years 9 months ago
Joint hypermobility linked to depression & anxiety? Longitudinal Study of 6105 kids at age 14 yrs: 19% had generalised joint hypermobility (more in F) *+& assoc w/ depression (OR: 3.53), anxiety (3.14) at age 18 https://t.co/9NrEfwt4L5 https://t.co/JrM2JKUuJ0
Dr. John Cush RheumNow
3 years 9 months ago
SLE preg delivery hospitalizations (77560) was associated with increased risk of CV complications, including preeclampsia [aOR 2.12] , peripartum cardiomyopathy (4.42), CHF (4), arrhythmias (2.2), AKI (7.7), stroke (4.8), VTE (6.9) w/ incr hosp costs https://t.co/PF6P8oDWZB https://t.co/jA2pHcciB1
Dr. Jack Cush reviews more than a dozen news and journal articles from this past week on RheumNow.com.
